Natalia Chaves

Dr. Natalia Chaves

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
JBJordan M. Broekhuis
Jordan M. Broekhuis
CLChun Li
Chun Li
HCHao Wei Chen
Hao Wei Chen
NCNatalia Chaves
Natalia Chaves
SDSarah Duncan
Sarah Duncan
BJBenjamin C. James
Benjamin C. James

2 October 2022 in Surgery
Verified
Journal Article
Closed access
JBJordan M. Broekhuis
Jordan M. Broekhuis
NCNatalia Chaves
Natalia Chaves
HCHao Wei Chen
Hao Wei Chen
FDF. Thurston Drake
F. Thurston Drake
BJBenjamin C. James
Benjamin C. James

29 August 2022 in Surgery
Verified
Journal Article
Closed access
RCReagan A. Collins
Reagan A. Collins
CDCatherine DiGennaro
Catherine DiGennaro
TBToni Beninato
Toni Beninato
RGRajshri M. Gartland
Rajshri M. Gartland
NCNatalia Chaves
Natalia Chaves
CLCarrie Cunningham Lubitz
Carrie Cunningham Lubitz

24 January 2022 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
NCNatalia Chaves
Natalia Chaves
MRM. Juanita Rodriguez
M. Juanita Rodriguez
JBJordan M. Broekhuis
Jordan M. Broekhuis
HCHao Wei Chen
Hao Wei Chen
PBPaul A. Bain
Paul A. Bain
BJBenjamin C. James
Benjamin C. James

21 November 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
JBJordan Broekhuis
Jordan Broekhuis
DLDongli Lu
Dongli Lu
RARajindra Aryal
Rajindra Aryal
YMYasuyuki Matsumoto
Yasuyuki Matsumoto
LPLauren Pepi
Lauren Pepi
Richard D. CummingsRichard D. Cummings
Richard D. Cummings
Aberrant protein glycosylation is a hallmark alteration of cancer and is highly associated with cancer progression. Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, but the N-glycosylation of its glycoproteins has not been well characterized. In this work, we analyzed multiple freshly prepared PTC specimens along with paired normal tissue obtained from thyroidectomies. Glycomic analyses focused on Asn-linked (N)-glycans and employed mass spectrometry (MS), along with Western blot approaches of total solubilized materials that were examined for binding by specific lectins and a monoclonal antibody (mAb) O6, specific for 3-O-sulfated galactose residues. We observed major differences in PTC versus paired normal specimens, as PTC specimens exhibited higher levels of N-glycan branching and bisection with N-acetylglucosamine residues, consistent with RNAseq data. We also found that 3-O-sulfated galactose was present in N-glycans of multiple glycoproteins from both PTC and control specimens, as recognized by the O6 mAb and as confirmed by MS analyses. These results provide new insights into the N-glycans present in glycoproteins of thyroid cancer and context for further studies of these altered glycans as biomarkers and targets for therapeutics.

3 November 2023 in Surgery
Verified
Journal Article
Closed access
JBJordan M. Broekhuis
Jordan M. Broekhuis
MCMaria P. Cote
Maria P. Cote
RCReagan A. Collins
Reagan A. Collins
JGJorge Gomez-Mayorga
Jorge Gomez-Mayorga
NCNatalia Chaves
Natalia Chaves
BJBenjamin C. James
Benjamin C. James